• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Pharma Pulse 4/5/24: Patient with Pig Kidney Goes Home, Combining AI and Market Access & more

News
Article

The latest news for pharma industry insiders.

The Synergies in Combining Artificial Intelligence and Market Access

Although AI has simplified various market access processes, this technology does also present its share of barriers, so what can be done to find a happy medium?

CMS Finalizes 2025 Rates for Medicare Advantage and Part D Plans

Market shares have fallen for CVS, UnitedHealth Group and more following the announcement.

Patient With Transplanted Pig Kidney Leaves Hospital for Home

Richard Slayman, 62, is the first patient to receive a kidney from a genetically modified pig. Two weeks after the procedure, he was well enough to be discharged, doctors said.

GoodRx Adds Publix to GoodRx Gold Network

Monthly healthcare membership now provides consumers with savings of up to 90% at more than 1,200 Publix locations

Petros Pharmaceuticals on LinkedIn:

In an interview with Pharmaceutical Executive, Fady Boctor, MBA discusses both the recent availability of Opill as an over-the-counter contraceptive and shares his insights on the future of OTC contraceptives.

Part 1: https://lnkd.in/dDKw_eZN
Part 2: https://lnkd.in/dVafVYjA

#PetrosPharma #OTCmarkets #contraceptives

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs